Balance Cream illustrates why a formula review begins with the declared ingredients rather than the product’s leading theme. Dr. Anna Cabeca’s page foregrounds wild yam and skin support, while its ingredient list names progesterone and pregnenolone. Those are essential parts of the record and should remain explicit in any comparison with prescription skincare.
The Formula Review checked the official listing on October 14, 2026. Balance appears here as a retail comparison, not as an established prescription substitute. We have not analyzed a sample, measured delivery into skin or observed a user’s response. The review distinguishes a named ingredient, an undisclosed concentration and a clinical conclusion that would require additional evidence.
Sponsored placement. The promoted prescription offer is separate from this retail product; no therapeutic equivalence or head-to-head advantage is established.
The current product record
- Access and category
- Retail hormone-containing cosmetic; evaluated as a comparison record
- Declared formula
- Progesterone, pregnenolone, Tripeptide-29 and a moisturizing base; hormone strengths not established
- Displayed offer
- $54.95 one-time or $47.26 recurring, with the selected shipment interval recorded separately
- Limit to retain
- An ingredient declaration establishes the seller’s stated composition, not measured hormone exposure or equivalence to estriol.
The plant starting material does not replace the ingredient name
The seller explains that its progesterone is made from a wild-yam-derived starting material. The relevant finished-product declaration still says progesterone. Describing the cream only as wild yam would leave out the ingredient that needs to be considered in a hormone-aware assessment.
Pregnenolone is also separately listed. Neither hormone is another name for estriol, and the formula cannot inherit the evidence or strength of an estriol face cream because the products address a similar customer audience. A comparison needs the actual molecule and preparation before it can ask what an effect might mean.
Tripeptide-29 adds a peptide component to the description. It does not turn the hormone ingredients into ordinary background materials, nor does it make the overall blend equivalent to a peptide-only cosmetic. The entire preparation remains the product being evaluated, with each category of ingredient raising its own questions.
What a declaration can and cannot establish
The public list identifies the moisturizing base and additional botanical ingredients, including lavender and lemongrass oils. That makes the declaration more useful than a short list of desirable actives. Someone with a known sensitivity can check a specific ingredient, while still confirming that the current supplied bottle carries the same label.
The list does not establish individual hormone concentrations or measured exposure from the marketed cream. Ingredient order and a pump description cannot provide those missing measurements. We do not infer an absorbed amount or a prescription-equivalent dose, and missing exposure information should not be presented as evidence that exposure is absent.
The supporting ingredients also matter to any finished-product study. A result involving an isolated peptide or hormone in another vehicle would not automatically validate Balance’s combination. The amount, base, intended area and endpoint would need to be connected to the actual marketed preparation before a stronger conclusion could be drawn.
The evidence needs to follow the complete preparation
Balance’s sales account includes cosmetic claims and customer descriptions of experiences involving sleep, mood and related concerns. Those accounts are different from controlled testing of the finished formula. This review did not independently appraise a complete product trial establishing treatment of those broader conditions.
The seller cautions that the ingredients may influence hormone levels and advises consultation before use. That warning is relevant even though the page calls the preparation cosmetic. A product category or a positive testimonial cannot determine suitability for someone with a hormone-sensitive condition or an existing hormone-treatment plan.
FDA guidance helps distinguish cosmetic appearance language from claims involving disease or body function. It does not provide this review with a product-specific approval finding. We did not verify FDA approval of finished Balance Cream; a professional credential, plant-origin description or manufacturing statement cannot serve as a substitute for that evidence.
| Record | Published detail | What it establishes |
|---|---|---|
| Names disclosed | Progesterone / pregnenolone | Keep both hormones in the formula description. |
| Amounts unresolved | Individual concentrations | No absorbed-dose or prescription-equivalence calculation. |
| Separate ingredient | Tripeptide-29 | Peptide mechanisms do not validate the entire combination. |
The formula belongs within the existing treatment record
A useful conversation with the responsible clinician includes the complete label, the reason for considering the cream and the current medicines or supplements. Calling it simply a moisturizer may omit the declared progesterone and pregnenolone. The purpose is to make the proposed preparation identifiable within the person’s actual care.
This publication does not adopt the seller’s application amount, body-area or menstrual-cycle instructions as individual advice. It has not assessed absorption, a treatment target or a monitoring plan for a particular person. Retail availability also does not show that combining the cream with prescribed hormones is appropriate.
The brand’s other items have distinct formulations and intended uses. A personal lubricant or intimate-area moisturizer cannot provide Balance’s regulatory status, exposure information or supporting studies. A shared catalog or bundle is a commercial relationship between products, not evidence that their clinical properties can be exchanged.
The selected charge does not complete the formula record
The official offer shows $54.95 for a one-time purchase and $47.26 for a recurring selection, with two- or three-month delivery choices. Those are commercial options. Their intervals do not disclose hormone concentration or establish a suitable application schedule, and the discounted charge should not be described as every buyer’s standalone price.
The source uses both supply-period and approximate application-count wording. We do not turn those descriptions into a verified personal duration. A calculation based on the wrong use assumption would make the price appear more precise while leaving the underlying clinical question unanswered.
US-only shipping and a $6.99 priority-packing option are also advertised. The additional fee concerns order handling, not quicker clinician review. We did not verify checkout, inventory for an address, successful delivery or cancellation. A purchase decision should retain the final charge, chosen recurrence and any extra costs rather than relying on the first number shown.
Put your actual quote into the calculation
Use the product charge and its stated supply period. This runs only in your browser; no entry is sent to us. A supply period is not a recommendation to continue treatment for that duration.
Enter a confirmed quote to see the monthly equivalent and first-order total. Unverified prices are not treated as zero.
Extra fees default to $0 for calculation only; this does not mean consultation, shipping or tax is free. Add known first-order fees. Later fees and repeat charges are not modeled. This is budgeting arithmetic, not a treatment recommendation.
The guarantee and the clinical uncertainty remain separate
A 60-day money-back guarantee is presented on the listing. Its complete conditions for opened goods or recurring shipments were not established here. We therefore do not promise a particular refund or an unrestricted full-bottle trial. Ask the seller which date starts the period and what authorization, return and deduction rules apply.
Those rules are useful purchase information, but they do not establish safety, efficacy or equivalence to a prescription. A financial remedy cannot substitute for the missing concentration and exposure record. Conversely, clinical advice about the ingredients does not determine whether a retailer will reimburse an order.
CoreAge Rx’s inclusion is disclosed promotion. Any proposed prescription has a different formula and assessment process to evaluate. This review does not establish an interchangeable dose, a head-to-head advantage or a reason to change existing care because another product appears prominently on the page.
What would make a formula-level conclusion stronger?
The key additions would be the current supplied label, disclosed hormone concentrations, relevant exposure information and the full report behind a desired finished-product outcome. The selected purchase terms should be documented separately. These records would answer different parts of the decision without allowing a headline or testimonial to stand in for all of them.
For now, the declaration’s explicit hormone names are a useful strength, while their unverified amounts and the limits of appraised product evidence remain substantial uncertainties. Balance is retained as a retail comparison that can inform questions. It is not presented as a personally tested product, an FDA-approved therapy or an equivalent replacement for prescribed hormone treatment.
Watch & understand
How to care for your skin during menopause
Background on caring for changing skin. The AAD video does not endorse this brand, compounded facial estriol, or any particular hormone prescription.
How to care for your skin during menopause
YouTube loads only after you choose “Load video.” This connects your browser to YouTube using its privacy-enhanced player. The video is educational and does not endorse this publication, this product or CoreAge Rx. Watch on YouTube ↗ · View the AAD page and written guidance ↗
Sources and the limits of this review
- drannacabeca.com/products/pura-balance-ppr-cream ↗
- www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-claims ↗
- www.aad.org/public/everyday-care/skin-care-secrets/prevent-skin-problems/test-skin-care-products/ ↗
Product, purchase and guidance pages were checked October 14, 2026. Manufacturer information establishes the advertised record; it is not independent verification of every result. No clinical consultation, laboratory analysis, purchase, return or personally observed outcome was completed for this review.